Publications

• Therapeutic plasma exchange for fibrinogen-associated hyperviscosity: results of the COVID-19 PLasma EXchange (COPLEX)randomized controlled trial.
  J Thromb Haemost Volume: 23 Page(s): 1393 - 1400
  04/01/2025 Authors: Maier CL; Nakahara H; Barker NA; Auld SC; Truong AD; Friend S; Caridi-Scheible M; Connor M; Gaddh M; Cobb J
• Three Cases Highlighting Three Potential Pitfalls in the Platelet Refractory Workup
  Volume: 158 Page(s): S160 - S160
  11/09/2022 Authors: Attieh M; Dent EA; Then CE; Barrette E; Alter DN; Duncan A; Roback JD; Sullivan HC; Happney L
• Establishing a combined Immunology/HLA/Coagulation Rotation for Pathology Residents
  Volume: 158 Page(s): S4 - S5
  11/09/2022 Authors: Dent EA; Duncan A; Sullivan HC; Gebel HM; Bray RA; Maier CL; Smith G; Guarner J
• A Sticky Situation: Variable Agreement Between Platelet Function Tests Used to Assess Anti-platelet Therapy Response.
  Front Cardiovasc Med Volume: 9 Page(s): 899594
  01/01/2022 Authors: Nakahara H; Sarker T; Dean CL; Skukalek SL; Sniecinski RM; Cawley CM; Guarner J; Duncan A; Maier CL
• Reducing Donor Specific Antibody via Therapeutic Plasma Exchange: Daily vs Every Other Day Protocols
  Volume: 61 Page(s): 23A - 23A
  09/01/2021 Authors: Wade J; Goodman A; Dent AE; Duncan A; Roback JD; Bray RA; Gebel HM; Sullivan HC
• Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
  Transfusion Volume: 61 Page(s): 1029 - 1034
  04/01/2021 Authors: Truong AD; Auld SC; Barker NA; Friend S; Wynn AT; Cobb J; Sniecinski RM; Tanksley C-L; Polly DM; Gaddh M
• Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.
  Am J Clin Pathol Volume: 155 Page(s): 498 - 505
  03/15/2021 Authors: Moosavi M; Wooten M; Goodman A; Nahab FB; Duncan A; Maier C; Guarner J
• Markers of Coagulation and Hemostatic Activation Identify Covid-19 Patients at High Risk for Thrombotic Events
  Volume: 52
  03/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL
• The Utility of the Markers of Coagulation and Hemostatic Activation Profile in the Management of Embolic Strokes of Undetermined Source.
  J Stroke Cerebrovasc Dis Volume: 30 Page(s): 105592
  03/01/2021 Authors: Liu M; Ellis D; Duncan A; Belagaje S; Belair T; Henriquez L; Rangaraju S; Nahab F
• Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
  J Clin Apher Volume: 36 Page(s): 34 - 40
  02/01/2021 Authors: Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC
• Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease.
  Clin Appl Thromb Hemost Volume: 27 Page(s): 10760296211032292
  01/01/2021 Authors: Miller MJ; Maier CL; Duncan A; Guarner J
• Validation of an admission coagulation panel for risk stratification of COVID-19 patients.
  PLoS One Volume: 16 Page(s): e0248230
  01/01/2021 Authors: Alabyad D; Rangaraju S; Liu M; Imran R; Kempton CL; Sharifpour M; Auld SC; Gaddh M; Sniecinski R; Maier CL
• Anticoagulation Therapy Reduces Recurrent Stroke in Embolic Stroke of Undetermined Source Patients With Elevated Coagulation Markers or Severe Left Atrial Enlargement.
  Front Neurol Volume: 12 Page(s): 695378
  01/01/2021 Authors: Patel K; Mikhael E; Liu M; Rangaraju S; Ellis D; Duncan A; Belagaje S; Belair T; Henriquez L; Nahab F
• Validation of PLASMIC score: an academic medical center case series (2012-present).
  Transfusion Volume: 60 Page(s): 1536 - 1543
  07/01/2020 Authors: Moosavi H; Ma Y; Miller MJ; Duncan A
• Passenger Lymphocyte Syndrome; a Review of the Diagnosis, Treatment, and Proposed Detection Protocol.
  Transfus Med Rev Volume: 34 Page(s): 178 - 187
  07/01/2020 Authors: Moosavi MM; Duncan A; Stowell SR; Roback JD; Sullivan HC
• COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
  Lancet Volume: 395 Page(s): 1758 - 1759
  06/06/2020 Authors: Maier CL; Truong AD; Auld SC; Polly DM; Tanksley C-L; Duncan A
• Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke.
  Neurology Volume: 94 Page(s): e1892 - e1899
  05/05/2020 Authors: Nahab F; Sharashidze V; Liu M; Rathakrishnan P; El Jamal S; Duncan A; Hoskins M; Marmarchi F; Belagaje S; Bianchi N
• Biomarkers of Coagulation and Hemostatic Activation in the Post-Acute Period Effectively Rule Out Hypercoagulable States in Patients with Embolic Stroke of Undetermined Source
  Volume: 94
  04/14/2020 Authors: Liu M; Rangaraju S; Ellis D; Duncan A; Belagaje S; Belair T; Henriquez L; Nahab F
• Biomarkers of Coagulation and Hemostatic Activation in the Post-Acute Period Effectively Rule Out Hypercoagulable States in Patients With Embolic Stroke of Undetermined Source
  Volume: 51
  02/01/2020 Authors: Liu M; Rangaraju S; Ellis D; Duncan A; Belagaje S; Belair T; Henriquez L; Nahab F
• Frequency of Hypercoagulability in Patients With Embolic Stroke of Undetermined Source and Patent Foramen Ovale
  Volume: 51
  02/01/2020 Authors: Liu M; Rangaraju S; Duncan A; Belagaje S; Belair T; Henriquez L; Nahab F
• Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency.
  J Blood Med Volume: 11 Page(s): 297 - 303
  01/01/2020 Authors: Peltier S; Kellum A; Brewer J; Duncan A; Cooper DL; Saad H
• Disease Burden in Patients with Glanzmann's Thrombasthenia: Perspectives from the Glanzmann's Thrombasthenia Patient/Caregiver Questionnaire.
  J Blood Med Volume: 11 Page(s): 289 - 295
  01/01/2020 Authors: Duncan A; Kellum A; Peltier S; Cooper DL; Saad H
• Disease Burden in Patients with Glanzmann Thrombasthenia: Perspectives from the Glanzmann Thrombasthenia Patient/Caregiver Questionnaire
  Volume: 134
  11/13/2019 Authors: Duncan A; Kellum A; Jain S; Peltier S; Smith H; Cooper D; Saad H
• A Sticky Situation: Poor Correlation Between Platelet Inhibition Assays
  Volume: 152 Page(s): S5 - S6
  10/01/2019 Authors: Dean CL; Duncan A; Ingle A; Guarner J; Roback JD; Sullivan HC; Maier C
• Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay.
  Am J Hematol Volume: 94 Page(s): E132 - E134
  05/01/2019 Authors: Maier CL; Asbury WH; Duncan A; Robbins A; Ingle A; Webb A; Stowell SR; Roback JD
• Anticoagulation Therapy Reduces Recurrent Stroke in Embolic Stroke of Undetermined Source (ESUS) Patients With Elevated Markers of Coagulation and Hemostatic Activation
  Volume: 50
  02/01/2019 Authors: Hassani S; Sharashidze V; Rangaraju S; Rathakrishnan P; Ellis D; Duncan A; Hoskins M; Marmarchi F; Belagaje S; Bianchi N
• Markers of Coagulation and Hemostatic Activation in Embolic Stroke of Undetermined Source (ESUS) Patients With Patent Foramen Ovale
  Volume: 50
  02/01/2019 Authors: Sharashidze V; Rangaraju S; Rathakrishnan P; Duncan A; Hoskins M; Marmarchi F; Belagaje S; Bianchi N; Belair T; Henriquez L
• Markers of Coagulation and Hemostatic Activation Identify Embolic Stroke of Undetermined Source (ESUS) Patients who are at Risk of Recurrent Thrombotic Events on Antiplatelet Therapy: A Validation Study
  Volume: 50
  02/01/2019 Authors: Sharashidze V; Rangaraju S; Rathakrishnan P; Duncan A; Hoskins M; Marmarchi F; Belagaje S; Bianchi N; Belair T; Henriquez L
• Development, Implementation, and Evaluation of a Fourth-Year Medical School Elective Course in Blood Banking and Transfusion Medicine.
  Volume: 151 Page(s): 116 - 121
  01/01/2019 Authors: Sullivan HC; Stowell SR; Meyer EK; Duncan AD; Guarner J
• Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke.
  Medicine (Baltimore) Volume: 97 Page(s): e13830
  12/01/2018 Authors: Ellis D; Rangaraju S; Duncan A; Hoskins M; Raza SA; Rahman H; Winningham M; Belagaje S; Bianchi N; Mohamed GA
• Anti-XA Assay Is a Poor Predictor of Direct Oral Anticoagulant Interference in Lupus Anticoagulant Tests
  Volume: 150 Page(s): S168 - S168
  10/01/2018 Authors: Guarner J; Maier C; Ingle A; Stowell S; Roback JD; Duncan A
• Measures of Coagulation and Hemostatic Activation Outperform Left Atrial Structural Parameters in Identifying Embolic Stroke of Undetermined Source (ESUS) Patients Who May Benefit From Early Anticoagulation
  Volume: 49
  01/01/2018 Authors: Ellis D; Rangaraju S; Duncan A; Hoskins MH; Raza SA; Rahman H; Winningham M; Belagaje S; Bianchi N; Belair T
• Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience.
  Arch Pathol Lab Med Volume: 141 Page(s): 329 - 340
  03/01/2017 Authors: Fasano RM; Sullivan HC; Bray RA; Gebel HM; Meyer EK; Winkler AM; Josephson CD; Stowell SR; Sandy Duncan A; Roback JD
• Pharmacogenetics in Oral Antithrombotic Therapy.
  Clin Lab Med Volume: 36 Page(s): 461 - 472
  09/01/2016 Authors: Maier CL; Duncan A; Hill CE
• Laboratory test support for Ebola patients within a high-containment facility.
  Lab Med Volume: 45 Page(s): e109 - e111
  01/01/2014 Authors: Hill CE; Burd EM; Kraft CS; Ryan EL; Duncan A; Winkler AM; Cardella JC; Ritchie JC; Parslow TG
• Can Markers of Coagulation Identify Types of Hepatic Disease?
  Volume: 140 Page(s): 433 - 433
  09/01/2013 Authors: Morrison AS; Sullivan HC; Martin DR; Winkler AM; Duncan A; Guarner J
• Prothrombin Fragment 1.2 and Other Coagulation Markers in Patients With Hepatitis C
  Volume: 140 Page(s): 433 - 434
  09/01/2013 Authors: Morrison AS; Sullivan HC; Martin DR; Winkler AM; Duncan A; Guarner J
• Measuring platelet aggregation integrals to predict thromboembolic complications in patients undergoing pipeline embolization for treatment of cerebral aneurysms
  Volume: 11 Page(s): 1142 - 1143
  07/01/2013 Authors: Maier CL; Schneider T; Smith G; Rutledge WC; Guarner J; Duncan AS; Winkler AM
• Laboratory quality control for all. Can this be achieved?
  Am J Clin Pathol Volume: 138 Page(s): 639 - 641
  11/01/2012 Authors: Guarner J; Duncan A; Nelson AM; Messele T
• Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?
  Chest Volume: 142 Page(s): 1175 - 1178
  11/01/2012 Authors: Zhou A; Winkler A; Emamifar A; Gartland B; Duncan A; Antun A; Arellano M; Tindol GA; Levy JH; Bornstein WA
• Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine.
  Transfusion Volume: 50 Page(s): 2193 - 2198
  10/01/2010 Authors: Winkler AM; Sheppard CA; Culler EE; Myers RL; Duncan A; Castillejo M-I; Hillyer CD; Josephson CD
• Dengue virus-induced hemorrhage in a nonhuman primate model.
  Blood Volume: 115 Page(s): 1823 - 1834
  03/04/2010 Authors: Onlamoon N; Noisakran S; Hsiao H-M; Duncan A; Villinger F; Ansari AA; Perng GC
• Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
  Ann Thorac Surg Volume: 88 Page(s): 1666 - 1668
  11/01/2009 Authors: Bolliger D; Sreeram G; Duncan A; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
• Evaluation of an automated assay for soluble fibrin monomers
  Volume: 7 Page(s): 854 - 854
  07/01/2009 Authors: Duncan A; Winkler A; Ingle A; Hostetler K
• Comparison of a novel ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method with the activated partial thromboplastin time (aPTT) and prothrombin time (PT)
  Volume: 7 Page(s): 363 - 363
  07/01/2009 Authors: Winkler AM; Synder ML; Duncan A; Molinaro RJ
• Dynamic Hypercoagulability Following Pancreas Transplantation.
  Volume: 9 Page(s): 616 - 617
  01/01/2009 Authors: Shen L; Agarwal A; Turgeon N; Tso P; Newell K; Pearson T; Larsen C; Winkler A; Duncan A; Kirk A
• The use of fondaparinux in pregnancy
  Volume: 123 Page(s): S146 - S146
  01/01/2009 Authors: Winkler AM; Duncan A
• Overview of pharmacogenetics in anticoagulation therapy.
  Clin Lab Med Volume: 28 Page(s): 513 - 524
  12/01/2008 Authors: Hill CE; Duncan A
• A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FX.
  Thromb Haemost Volume: 98 Page(s): 1165 - 1169
  12/01/2007 Authors: Ameri A; Machiah DK; Tran TT; Channell C; Crenshaw V; Fernstrom K; Khachidze M; Duncan A; Fuchs S; Howard TE
• Small volume storage of apheresis platelets for pediatric use: A study of platelet metabolism and function
  Volume: 46 Page(s): 10A - 10A
  09/01/2006 Authors: Josephson CD; Culler EE; Emory MR; Duncan A; Castillejo M; Jessup PL; Myers RL; Hillyer CD
• Preanalytical variables in coagulation testing.
  Blood Coagul Fibrinolysis Volume: 17 Page(s): 425 - 426
  07/01/2006 Authors: Sheppard CA; Channell C; Ritchie JC; Duncan A
• Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis.
  Liver Transpl Volume: 12 Page(s): 972 - 978
  06/01/2006 Authors: Heffron T; Welch D; Pillen T; Asolati M; Smallwood G; Hagedorn P; Nam C; Duncan A; Guy M; Martinez E
• Detection and identification of cytochrome P-450 2C9 alleles *1, *2, and *3 by high-resolution melting curve analysis of PCR amplicons.
  Am J Clin Pathol Volume: 125 Page(s): 584 - 591
  04/01/2006 Authors: Hill CE; Duncan A; Wirth D; Nolte FS
• Management of a patient with recurrent pregnancy loss secondary to primary antiphospholipid antibody syndrome via therapeutic plasma exchange
  Volume: 115 Page(s): 116 - 117
  02/01/2005 Authors: Cushing MM; Nolen JDL; Duncan A
• Lipoprotein(a) assessment in a population of high-risk obstetric patients
  Volume: 115 Page(s): 147 - 147
  02/01/2005 Authors: Webber BA; Nolen JDL; Duncan A
• Modeling and refinement of lupus anticoagulant testing via neural network analysis
  Volume: 114 Page(s): 665 - 665
  01/01/2004 Authors: Nolen JDL; Sheppard CA; Duncan A
• Recombinant factor VIIa (rFVIIa) as a safe and effective therapeutic option for the correction of moderate to severe hepatic coagulopathy.
  Volume: 38 Page(s): 482A - 482A
  10/01/2003 Authors: Wehbi MA; Obideen K; Martinez E; Duncan A
• Antithrombin deficiency: issues in laboratory diagnosis.
  Volume: 126 Page(s): 1326 - 1336
  11/01/2002 Authors: Kottke-Marchant K; Duncan A
• Hirudin causes false-positive assays for lupus anticoagulants.
  Volume: 118 Page(s): 651 - 652
  10/01/2002 Authors: Sgan SL; Channell C; Waddy S; Green K; Benson E; Hillyer CD; Duncan A; Howard TE
• Recombinant FVIIa(novoseven)treatment of hepatic coagulopathies.
  Volume: 36 Page(s): 515A - 515A
  10/01/2002 Authors: Duncan A; Martinez EJ
• Determination of the average percent von Willebrand Factor-cleaving protease (vWF-CP) activity in donor plasma.
  BLOOD Volume: 98 Page(s): 539A - 540A
  11/16/2001 Authors: Kelley VA; Hillyer KL; Roush KR; Long EL; Barclay SB; Duncan A; Hillyer CD
• The G20210A mutation increases stability of the prothrombin (f-II) mRNA; Possible mechanism for increased plasma f-II levels and thrombosis risk.
  BLOOD Volume: 98 Page(s): 259A - 259A
  11/16/2001 Authors: Howard TE; Meng XP; Meszane L; Robida AM; Xu KM; Duncan A; Murphy TJ
• von Willebrand factor-cleaving protease (vWF-CP) activity in S59-treated donor plasma.
  BLOOD Volume: 98 Page(s): 539A - 539A
  11/16/2001 Authors: Hillyer KL; Kelley VA; Roush KS; Long EL; Barclay SB; Duncan A; Roback JD; Hillyer CD
• vWF-cleaving metalloprotease (MP) activity: Comparison of fresh frozen plasma (FFP), cryosupernatant (CS), and solvent detergent treated plasma (SDP)
  TRANSFUSION Volume: 41 Page(s): 37S - 37S
  09/01/2001 Authors: Roush KS; Hillyer KL; Barclay S; Kelley VA; Duncan A; Roback JD; Hillyer CD
• Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
  Bone Marrow Transplant Volume: 27 Page(s): 635 - 639
  03/01/2001 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
• Novel polymorphisms of the human coagulation factor IX (fIX) gene.
  BLOOD Volume: 96 Page(s): 640A - +
  11/16/2000 Authors: Howard TE; Meng XP; Patel RM; Iber JC; Duncan A; Lollar JS; Warren ST
• Effects of vitamin K-dependent procoagulant factor deficiency states on clot-based lupus anticoagulant assays.
  BLOOD Volume: 96 Page(s): 642A - 643A
  11/16/2000 Authors: Webber B; Howard TE; Ingles A; Benson L; Channell C; Ray GS; Duncan A
• Comparison of coagulation factor activity in thawed F24, FFP, and cryosupernatant (CS) stored up to 5 days at 4 degrees C
  TRANSFUSION Volume: 40 Page(s): 60S - 60S
  10/01/2000 Authors: Fields AC; Lankford KV; Duncan A; Benson E; Allen M; Hillyer CD
• Plasma exchange (TPE) for elevated lipoprotein(a) (Lp(a)) in a patient with xanthoma disseminatum (XD).
  TRANSFUSION Volume: 39 Page(s): 9S - 9S
  10/01/1999 Authors: Hill CE; Lankford KV; Brown WV; Duncan A; Hillyer CD
• Lab monitoring of the hypercoagulable pregnancy state: Three patients with various hypercoagulable risk factors followed with serial MOCHA (markers of coagulation and hemostasis activation) studies
  THROMBOSIS AND HAEMOSTASIS Page(s): 664 - 664
  08/01/1999 Authors: Kendall D; Duncan A; Channel C
• Coordinate expression of elevated prothrombin and factor X levels; A potential novel mechanism of thrombophilia
  THROMBOSIS AND HAEMOSTASIS Page(s): 542 - 542
  08/01/1999 Authors: Howard TE; Viel K; Channell C; Duncan A
• Utilization and specificity of indirect platelet antibody testing in an academic medical center
  THROMBOSIS AND HAEMOSTASIS Page(s): 644 - 644
  08/01/1999 Authors: Duncan A; Barclay S; Hillyer CD
• The prothrombin gene 3'-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency.
  Blood Volume: 91 Page(s): 1092
  02/01/1998 Authors: Howard TE; Marusa M; Boisza J; Young A; Sequeira J; Channell C; Guy C; Benson E; Duncan A
• Simultaneous expression of red cell autoantibodies and anti-cardiolipin antibodies
  MODERN PATHOLOGY Volume: 11 Page(s): 166A - 166A
  01/01/1998 Authors: Trainor LD; Benson EZ; Barclay SB; Hillyer CD; Duncan A
• Serial measurement of serum hyaluronic acid in veno-occlusive disease (VOD) following bone marrow transplantation (BMT): Correlation with severity
  HEPATOLOGY Volume: 26 Page(s): 82 - 82
  10/01/1997 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Strauss RM; Boyer TD; McDonald GB
• Significant disseminated intravascular coagulopathy (DIC) with secondary fibrinolysis identified during orthotopic liver transplantation (OLT).
  TRANSFUSION Volume: 37 Page(s): S421 - S421
  09/01/1997 Authors: Roback JD; Trainor LD; Levy JH; Kreger SM; Gordon RD; Duncan A; Hillyer CD
• Analysis of intraoperative blood component use during liver transplantation.
  TRANSFUSION Volume: 37 Page(s): S423 - S423
  09/01/1997 Authors: Trainor LD; Burkes JB; Barclay SB; Allen MB; Gordon RD; Duncan A; Hillyer CD
• A patient homozygous for a mutation in the prothrombin gene 3'-untranslated region associated with massive thrombosis.
  Blood Coagul Fibrinolysis Volume: 8 Page(s): 316 - 319
  07/01/1997 Authors: Howard TE; Marusa M; Channell C; Duncan A
• High prevalence of platelet specific allo-antibodies in liver disease patients with anti-phospholipid antibodies
  THROMBOSIS AND HAEMOSTASIS Page(s): P2190 - P2190
  06/01/1997 Authors: Duncan A; Roback JD; Barclay S; Hillyer CD
• Novel serum markers for veno-occlusive disease of the liver after bone marrow transplantation
  THROMBOSIS AND HAEMOSTASIS Page(s): OC731 - OC731
  06/01/1997 Authors: Roback JD; Guy C; Fried M; Duncan A
• Markers of coagulation & hemostasis activation (MOCHA) as indicators of unsuspected malignancy
  THROMBOSIS AND HAEMOSTASIS Page(s): PS502 - PS502
  06/01/1997 Authors: Duncan A; Howard T; League A
• Serum hyaluronic acid as a marker of liver injury in venoocclusive disease (VOD) following bone marrow transplantation (BMT).
  HEPATOLOGY Volume: 24 Page(s): 1355 - 1355
  10/01/1996 Authors: Fried MW; Duncan A; Soroka S; Connaghan DG; Ruocco C; Strauss RM; Boyer TD
• Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
  Am J Vet Res Volume: 57 Page(s): 427 - 431
  04/01/1996 Authors: Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
• ASSOCIATION OF PROCOAGULANT ACTIVITY WITH ENHANCED MALARIA IN MICE
  Volume: 9 Page(s): A231 - A231
  03/09/1995 Authors: RYAN KR; KIDD MR; DUNCAN A; LAL AA; HUNTER RL
• Chemotherapy-induced hemolytic uremic syndrome: description of a potential animal model.
  J Med Primatol Volume: 24 Page(s): 68 - 73
  02/01/1995 Authors: Hillyer CD; Duncan A; Ledford M; Barrett TJ; Klumpp SA; Anderson DC; McClure HM; Winton EF
• HEMOSTASIS ACTIVATION MARKERS IN PATIENTS UNDERGOING AORTO-BI-ILIAC GRAFT-SURGERY
  THROMBOSIS AND HAEMOSTASIS Volume: 69 Page(s): 1168 - 1168
  06/30/1993 Authors: DUNCAN A; LUMSDEN AB
• CHEMOTHERAPY-INDUCED HEMOLYTIC-UREMIC SYNDROME - DESCRIPTION OF A POTENTIAL ANIMAL-MODEL
  THROMBOSIS AND HAEMOSTASIS Volume: 69 Page(s): 1027 - 1027
  06/30/1993 Authors: HILLYER CD; DUNCAN A; LEDFORD M; BARRETT TJ; KLUMPP SA; ANDERSON DC; MCCLURE HM; WINTON EF
• EVALUATION OF A TEST OF FIBRINOLYTIC POTENTIAL (FIBRISCREEN(TM)) IN POST OPERATIVE PATIENTS
  THROMBOSIS AND HAEMOSTASIS Volume: 69 Page(s): 835 - 835
  06/30/1993 Authors: DUNCAN A; PANKOWSKY DA
• A NOVEL PHOSPHOLIPID REAGENT FOR USE IN THE PLATELET NEUTRALIZATION PROCEDURE TEST
  THROMBOSIS AND HAEMOSTASIS Volume: 69 Page(s): 1032 - 1032
  06/30/1993 Authors: DUNCAN A; MULLINS RE; MAXWELL LM
• Elevated D dimer in the lungs and blood of patients with sarcoidosis.
  Chest Volume: 103 Page(s): 1100 - 1106
  04/01/1993 Authors: Perez RL; Duncan A; Hunter RL; Staton GW
• Malignant angioendotheliomatosis presenting as disseminated intravascular coagulopathy.
  Cancer Volume: 68 Page(s): 2319 - 2323
  11/15/1991 Authors: Stahl RL; Chan W; Duncan A; Corley CC
• Therapy of the Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid.
  Am J Hematol Volume: 36 Page(s): 272 - 274
  04/01/1991 Authors: Stahl RL; Henderson JM; Hooks MA; Martin LG; Duncan A
• A hypercoagulable state follows orthotopic liver transplantation.
  Hepatology Volume: 12 Page(s): 553 - 558
  09/01/1990 Authors: Stahl RL; Duncan A; Hooks MA; Henderson JM; Millikan WJ; Warren WD
• Antigenic assay for protein C determination in horses.
  Am J Vet Res Volume: 51 Page(s): 1075 - 1079
  07/01/1990 Authors: Welles EG; Prasse KW; Duncan A; Morris MJ
• Chromogenic assay for equine plasminogen.
  Am J Vet Res Volume: 51 Page(s): 1080 - 1085
  07/01/1990 Authors: Welles EG; Prasse KW; Duncan A
• EVIDENCE FOR THE EXCLUSIVE HEPATIC-CLEARANCE OF D-DIMER FRAGMENTS
  THROMBOSIS AND HAEMOSTASIS Volume: 62 Page(s): 183 - 183
  08/19/1989 Authors: DUNCAN A; STAHL R
• PEDIATRIC LUPUS ASSOCIATED WITH A CIRCULATING ANTICOAGULANT AND SEVERE FACTOR-II DEFICIENCY
  THROMBOSIS AND HAEMOSTASIS Volume: 62 Page(s): 377 - 377
  08/19/1989 Authors: DUNCAN A; RAWLINS P; BELL BA
• PROTEIN-C ACTS AS AN ACUTE PHASE REACTANT IN EQUINE LAMINITIS
  THROMBOSIS AND HAEMOSTASIS Volume: 58 Page(s): 109 - 109
  07/06/1987 Authors: PRASSE KW; MOORE JN; DUNCAN A
• PREVALANCE OF PRIMARY COAGULATION DEFICIENCIES IN PATIENTS WITH DEEP VENOUS THROMBOSIS
  THROMBOSIS AND HAEMOSTASIS Volume: 58 Page(s): 72 - 72
  07/06/1987 Authors: GROSSMAN B; DUNCAN A
• Thrombocytopenia caused by frusemide-induced platelet antibody.
  Lancet Volume: 1 Page(s): 1210
  05/30/1981 Authors: Duncan A; Moore SB; Barker P
• AUTOMATED COAGULATION-FACTOR ASSAYS USING A THROMBIN SPECIFIC CHROMOGENIC SUBSTRATE
  THROMBOSIS AND HAEMOSTASIS Volume: 46 Page(s): 313 - 313
  01/01/1981 Authors: DUNCAN A; BOWIE EJW; OWEN CA
• AUTOMATED ACTIVATED PARTIAL THROMBOPLASTIN APT SCREEN USING A THROMBIN SPECIFIC CHROMOGENIC SUBSTRATE
  FEDERATION PROCEEDINGS Volume: 40 Page(s): 807 - 807
  01/01/1981 Authors: DUNCAN A; BOWIE EJW; OWEN CA
• THE INFLUENCE OF PHYSIOLOGICAL-PARAMETERS ON THE PLASMA-CONCENTRATION OF BETA-THROMBOGLOBULIN (BETA-TG) AND PLATELET FACTOR-4 (PF-4) IN NORMAL HEALTHY-SUBJECTS
  THROMBOSIS AND HAEMOSTASIS Volume: 46 Page(s): 28 - 28
  01/01/1981 Authors: DUNCAN A; DIDISHEIM P
• Beta-thromboglobulin levels and oral contraception.
  Lancet Volume: 2 Page(s): 631
  09/22/1979 Authors: Duncan A